Management of Elevated PTH in Osteoporosis Patients

Diagnostic Evaluation

The Endocrine Society suggests that secondary hyperparathyroidism is characterized by elevated PTH with normal calcium levels, whereas primary hyperparathyroidism presents with elevated or high-normal calcium alongside elevated PTH 3
Verification of dietary calcium intake is essential through detailed dietary evaluation, as low urinary calcium excretion suggests calcium deprivation even when serum calcium appears normal 1, 2
Rechecking 25-OH vitamin D levels is necessary to confirm they are truly adequate (>20 ng/ml), as vitamin D deficiency is the most common reversible cause of secondary hyperparathyroidism 3, 1
Assessment of renal function with serum creatinine and eGFR is crucial, as declining kidney function commonly causes secondary hyperparathyroidism by impairing phosphate excretion and vitamin D activation 1, 2
Measuring 24-hour urinary calcium excretion helps evaluate for hypercalciuria (>300 mg/24h) or hypocalciuria (<100 mg/24h), which aids in differentiating the underlying cause and guiding treatment adjustments 1

The American College of Endocrinology recommends supplementing with native vitamin D (cholecalciferol) targeting 25-OH vitamin D levels >20 ng/ml, even if current levels are reported as "normal" 1, 2
Ensuring dietary calcium intake of 950 mg/day for adults through dietary sources or supplementation if dietary intake is inadequate is advised 1, 2
Rechecking PTH in 3 months after optimizing vitamin D and calcium is necessary to assess response 1
Monitoring serum calcium and urinary calcium is essential to ensure supplementation does not cause hypercalcemia or hypercalciuria 1, 2

Consider increasing active vitamin D (calcitriol) under close monitoring if PTH remains significantly elevated (>100 pg/ml) after 3-6 months of optimized vitamin D and calcium, though this is typically reserved for patients with chronic kidney disease 4, 1
Calcimimetic therapy (cinacalcet) may be considered for severe persistent hyperparathyroidism, but use with extreme caution as it can cause hypocalcemia and QT prolongation 4, 2
Parathyroidectomy should be considered only for persistent hypercalcemic hyperparathyroidism that fails medical management 4, 2

Avoid excessive vitamin D supplementation that could cause hypercalciuria and nephrocalcinosis, particularly in patients already on bisphosphonates 4